Literature DB >> 6684472

The sex hormone profile of male patients with breast cancer.

D Nirmul, R J Pegoraro, I Jialal, C Naidoo, S M Joubert.   

Abstract

The mean total serum oestradiol level was found to be significantly increased in 8 patients with carcinoma of the breast when compared with 8 healthy reference subjects matched for race, sex and age. The calculated mean free oestradiol index was also higher in these patients. There were no significant differences, however, between the levels of LH, FSH, prolactin. DHEA-S, testosterone and SHGB in the 2 groups. The patients showed a significantly increased LH response to GnRH while there was no difference in the FSH response. Only 1/7 patients had a tumour devoid of steroid hormone receptors. It may be that an increased level of circulating oestradiol-17 beta is an important factor in the aetiology of hormone-dependent male breast cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684472      PMCID: PMC2011477          DOI: 10.1038/bjc.1983.208

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

Review 1.  Prolactin and breast carcinoma.

Authors:  F Smithline; L Sherman; D Kolodny
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

2.  The treatment of cancer, especially inoperable cancer, of the male breast by ablative surgery (orchiectomy, adrenalec tomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids); an analysis of 42 patients.

Authors:  N TREVES
Journal:  Cancer       Date:  1959 Jul-Aug       Impact factor: 6.860

3.  Immunological and karyological criteria for identification of cell lines.

Authors:  V DEFENDI; R E BILLINGHAM; W K SILVERS; P MOORHEAD
Journal:  J Natl Cancer Inst       Date:  1960-08       Impact factor: 13.506

4.  Plasma estrogens and androgens in male breast cancer.

Authors:  E Calabresi; G De Giuli; A Becciolini; P Giannotti; G Lombardi; M Serio
Journal:  J Steroid Biochem       Date:  1976-08       Impact factor: 4.292

5.  A rapid method for the measurement of sex hormone binding globulin capacity of sera.

Authors:  B T Rudd; N M Duignan; D R London
Journal:  Clin Chim Acta       Date:  1974-09-16       Impact factor: 3.786

6.  The role of orchiectomy in the management of advanced male breast cancer.

Authors:  J P Neifeld; F Meyskens; D C Tormey; N Javadpour
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

7.  Nuclear and cytoplasmic oestrogen receptors in human mammary carcinoma.

Authors:  R J Pegoraro; W P Soutter; S M Joubert; D Nirmul; J V Bryer
Journal:  S Afr Med J       Date:  1980-11-15

8.  Clinical correlations of steroid receptors and male breast cancer.

Authors:  R B Everson; M E Lippman; E B Thompson; W L McGuire; J L Wittliff; E R De Sombre; E V Jensen; A Singhakowinta; S C Brooks; J P Neifeld
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

9.  Hormone receptors in male breast carcinoma.

Authors:  S J Ruff; J E Bauer; E J Keenan; H S Moseley; W S Fletcher
Journal:  J Surg Oncol       Date:  1981       Impact factor: 3.454

10.  Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer.

Authors:  R J Pegoraro; D Nirmul; S M Joubert
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

View more
  9 in total

1.  Synchronous bilateral breast carcinoma in a 50-year-old man with 45,X/46,XY mosaic karyotype: report of a case.

Authors:  Gianluca Franceschini; Pierfrancesco D'Alba; Melania Costantini; Andrea Magistrelli; Paolo Belli; Antonino Mulè; Claudio Coco; Aurelio Picciocchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer.

Authors:  M Chavez-MacGregor; H Zhao; M Kroll; S Fang; N Zhang; G N Hortobagyi; T A Buchholz; Y-C Shih; S H Giordano
Journal:  Ann Oncol       Date:  2011-03-10       Impact factor: 32.976

3.  Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.

Authors:  Kiyoshi Takagi; Takuya Moriya; Masafumi Kurosumi; Kimako Oka; Yasuhiro Miki; Akiko Ebata; Takashi Toshima; Shoji Tsunekawa; Hiroyuki Takei; Hisashi Hirakawa; Takanori Ishida; Shin-Ichi Hayashi; Junichi Kurebayashi; Hironobu Sasano; Takashi Suzuki
Journal:  Horm Cancer       Date:  2012-10-18       Impact factor: 3.869

4.  The low plasma testosterone levels of young Indian infarct survivors are not due to a primary testicular defect.

Authors:  M Sewdarsen; I Jialal; R K Naidu
Journal:  Postgrad Med J       Date:  1988-04       Impact factor: 2.401

5.  Clinicopathologic characteristics and survival of male breast cancer.

Authors:  Dongying Liu; Guangru Xie; Ming Chen
Journal:  Int J Clin Oncol       Date:  2013-05-03       Impact factor: 3.402

6.  A Case Control Study on Serum Levels of Potential Biomarkers in Male Breast Cancer Patients.

Authors:  Kamal Eldin Ahmed Abdelsalam; Mohammed Asad; Monjid Ahmed Ibrahim Ahmed; Syed Mohammed Basheeruddin Asdaq; Yahya Mohzari; Ahmed Alrashed; NajwaJilan Alghamdi; Kholoud Nasser Alrami; Wael Ahmed Alharbi
Journal:  Int J Environ Res Public Health       Date:  2021-05-01       Impact factor: 3.390

7.  Male breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester.

Authors:  G Ribeiro
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

8.  Role of aminoglutethimide in male breast cancer.

Authors:  A L Harris; M Dowsett; R Stuart-Harris; I E Smith
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

9.  Risk factors for male breast cancer.

Authors:  B D'Avanzo; C La Vecchia
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.